Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022

Author:

Bastard Jonathan1ORCID,Taisne Benjamin1,Figoni Julie1,Mailles Alexandra1ORCID,Durand Julien1,Fayad Myriam1,Josset Laurence23,Maisa Anna1ORCID,van der Werf Sylvie45,Parent du Châtelet Isabelle1,Bernard-Stoecklin Sibylle1

Affiliation:

1. Santé publique France, French national public health agency, Saint-Maurice, France

2. CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France

3. Laboratoire de Virologie, Institut des Agents Infectieux, Laboratoire associé au Centre National de Référence des virus des infections respiratoires, Hospices Civils de Lyon, Lyon, France

4. National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France

5. Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur, CNRS UMR 3569, Université Paris Cité, Paris, France

Abstract

Since the first reports in summer 2020, SARS-CoV-2 reinfections have raised concerns about the immunogenicity of the virus, which will affect SARS-CoV-2 epidemiology and possibly the burden of COVID-19 on our societies in the future. This study provides data on the frequency and characteristics of possible reinfections, using the French national COVID-19 testing database. The Omicron variant had a large impact on the frequency of possible reinfections in France, which represented 3.8% of all confirmed COVID-19 cases since December 2021.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference19 articles.

1. Protection against the Omicron variant from previous SARS-CoV-2 infection.;Altarawneh;N Engl J Med,2022

2. Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022.;Eggink;Euro Surveill,2022

3. Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.;Kuhlmann;Lancet,2022

4. World Health Organization (WHO). Weekly epidemiological update on COVID-19 - 22 February 2022. Edition 80. Geneva: WHO; 2022. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---22-february-2022

5. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.;Planas;Nature,2022

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3